First Allied Advisory Services’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
First Allied Advisory Services's CRL Position: Q3 2020 in Review
First Allied Advisory Services increased its Charles River Laboratories (CRL) stake by 2.7% in Q3 2020, buying an estimated $8.09K and bringing the position to 1,467 shares worth $332K. The position accounts for 0.01% of the portfolio, ranked #860.
First Allied Advisory Services first reported a position in CRL in Q4 2019 and has held it in 3 quarters since. 491 funds tracked by Wall St. Rank hold CRL as of Q3 2020.
- First Allied Advisory Services held 1,467 shares of Charles River Laboratories worth $332K as of Q3 2020.
- First Allied Advisory Services bought 39 Charles River Laboratories shares in Q3 2020, an estimated $8.09K.
- Charles River Laboratories made up 0.01% of First Allied Advisory Services's portfolio in Q3 2020, its #860 holding.
- First Allied Advisory Services first reported a position in Charles River Laboratories in Q4 2019 and has held it in 3 quarters since.
- 491 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2020.
Based on First Allied Advisory Services's 13F filing for Q3 2020, filed 13 Nov 2020.